Flavored Vaping for Tobacco Cessation
(REFLECT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This clinical trial studies whether different flavored electronic nicotine delivery systems (ENDS) help lower smoking and exposure to tobacco toxicants among cigarette smokers interested in reducing their smoking. ENDS are battery-powered electronic devices designed to deliver a nicotine-containing liquid solution for inhalation. They do not burn tobacco. Previous research has shown that ENDS have the potential to lower exposure to potentially toxic substances compared to burned cigarettes as well as lower short-term adverse health outcomes. However, there are many different ENDS products with varying characteristics, including different flavors, and a need remains to understand more how flavors affect ENDS use, the potential reduction in cigarette use, and exposure to toxicants. This trial studies how two different flavors, fruit and tobacco, affect an individual's smoking behavior and ultimately whether flavored ENDS can help lower smoking and exposure to tobacco toxicants among cigarette smokers interested in reducing their smoking.
Are You a Good Fit for This Trial?
This trial is for adults who currently smoke cigarettes and are interested in reducing or quitting smoking. Participants should be willing to try electronic nicotine delivery systems (vapes) with either fruit or tobacco flavors.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares the effects of using fruit-flavored versus tobacco-flavored vaping devices (ENDS) on cigarette use and exposure to harmful substances. Biospecimen samples will be collected to measure changes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants receive and use tobacco flavored ENDS ad libitum for 12 months in the absence of unacceptable toxicity. Participants also undergo urine sample collection on study.
Participants receive and use fruit flavored ENDS ad libitum for 12 months in the absence of unacceptable toxicity. Participants also undergo urine sample collection on study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Roswell Park Cancer Institute
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.